Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
COVID leaves singular signature on transplanted lungs | KLAS spots trends
Friday, September 30, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Transplanted lungs react to COVID in a distinctive way

Clinicians treating COVID-19 patients who have transplanted lungs and lower airway infection should order molecular testing in addition to, or regardless of, imaging findings.

READ MORE >
18_97_illustration_of_lung_structure_from_ct_scan_data_credit_university_of_southampton_web.jpg_sia_jpg_fit_to_width_inline.jpg
Share on Twitter Share on Facebook Share on Linkedin

Transplanted lungs react to COVID in a distinctive way

Share on Twitter Share on Facebook Share on Linkedin
18_97_illustration_of_lung_structure_from_ct_scan_data_credit_university_of_southampton_web.jpg_sia_jpg_fit_to_width_inline.jpg
Clinicians treating COVID-19 patients who have transplanted lungs and lower airway infection should order molecular testing in addition to, or regardless of, imaging findings.
READ MORE >

FDA clears 2D image-reconstruction product for 3D MRI

GE Healthcare may ship its deep learning-based image reconstruction software called AIR Recon DL with new 3D capabilities, the company announced Sept. 29.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA clears 2D image-reconstruction product for 3D MRI

Share on Twitter Share on Facebook Share on Linkedin
GE Healthcare may ship its deep learning-based image reconstruction software called AIR Recon DL with new 3D capabilities, the company announced Sept. 29.
READ MORE >

VIDEO: 6 key trends in PACS and radiology informatics observed by KLAS

Monique Rasband, vice president of imaging, cardiology and oncology, KLAS Research, shares some of technology trends observed in radiology PACS and and imaging informatics since 2019.

READ MORE >
Monique Rasband from KLAS Research shares trends in PACS and radiology informatics.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: 6 key trends in PACS and radiology informatics observed by KLAS

Share on Twitter Share on Facebook Share on Linkedin
Monique Rasband from KLAS Research shares trends in PACS and radiology informatics.
Monique Rasband, vice president of imaging, cardiology and oncology, KLAS Research, shares some of technology trends observed in radiology PACS and and imaging informatics since 2019.
READ MORE >

Featured Articles

New amyloid buster significantly hinders Alzheimer’s advance

An experimental Alzheimer’s drug therapy has slowed cognitive and functional decline by 27% versus placebo in a double-blind, randomized study of 1,795 individuals with early signs and symptoms of the disease.

READ MORE >
Dementia Alzheimers
Share on Twitter Share on Facebook Share on Linkedin

New amyloid buster significantly hinders Alzheimer’s advance

Share on Twitter Share on Facebook Share on Linkedin
Dementia Alzheimers
An experimental Alzheimer’s drug therapy has slowed cognitive and functional decline by 27% versus placebo in a double-blind, randomized study of 1,795 individuals with early signs and symptoms of the disease.
READ MORE >

For monitoring purposes, AI-aided MRI does what liver biopsy does with less risk, lower cost

Patients with autoimmune hepatitis may be better monitored across disease stages by AI-augmented multiparametric MRI than by liver biopsy, as the imaging has proven less costly and is inherently less risky due to its noninvasiveness. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

For monitoring purposes, AI-aided MRI does what liver biopsy does with less risk, lower cost

Share on Twitter Share on Facebook Share on Linkedin
Patients with autoimmune hepatitis may be better monitored across disease stages by AI-augmented multiparametric MRI than by liver biopsy, as the imaging has proven less costly and is inherently less risky due to its noninvasiveness. 
READ MORE >

In Case You Missed It

RSNA to shutter print journals

Collectors of medical memorabilia may want to plan on preserving the January 2023 print edition of Radiology.

READ MORE >
rsna_radiology_journal.jpg
Share on Twitter Share on Facebook Share on Linkedin

RSNA to shutter print journals

Share on Twitter Share on Facebook Share on Linkedin
rsna_radiology_journal.jpg
Collectors of medical memorabilia may want to plan on preserving the January 2023 print edition of Radiology.
READ MORE >

On review, popular imaging decision aid earns 1 thumbs-up—with caveats

With 91% sensitivity but only 25% specificity, the tool is worthwhile for clinicians who remain wary of frequent false positives that would send patients with no fractures for unneeded imaging.

READ MORE >
sports_injury.jpg
Share on Twitter Share on Facebook Share on Linkedin

On review, popular imaging decision aid earns 1 thumbs-up—with caveats

Share on Twitter Share on Facebook Share on Linkedin
sports_injury.jpg
With 91% sensitivity but only 25% specificity, the tool is worthwhile for clinicians who remain wary of frequent false positives that would send patients with no fractures for unneeded imaging.
READ MORE >

In Other News

A new Alzheimer's drug therapy appears effective. What might this mean for the future of amyloid PET?

Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).

READ MORE >
An example of a positive amyloid plaque PET nuclear brain scan. these tests can help identify Alzheimer's patients earlier so they can be prescribed drugs to treat the condition.
Share on Twitter Share on Facebook Share on Linkedin

A new Alzheimer's drug therapy appears effective. What might this mean for the future of amyloid PET?

Share on Twitter Share on Facebook Share on Linkedin
An example of a positive amyloid plaque PET nuclear brain scan. these tests can help identify Alzheimer's patients earlier so they can be prescribed drugs to treat the condition.
Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).
READ MORE >

VIDEO: Understanding biases in healthcare AI

Validation and testing of all algorithms is needed to eliminate any biases in the data used to train the AI, according to Julius Bogdan, vice president and general manager of the HIMSS Digital Health Advisory Team for North America.

READ MORE >
Validation and testing of all artificial intelligence (AI) algorithms is needed to eliminate any biases in the data used to train the AI, according to HIMSS.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Understanding biases in healthcare AI

Share on Twitter Share on Facebook Share on Linkedin
Validation and testing of all artificial intelligence (AI) algorithms is needed to eliminate any biases in the data used to train the AI, according to HIMSS.
Validation and testing of all algorithms is needed to eliminate any biases in the data used to train the AI, according to Julius Bogdan, vice president and general manager of the HIMSS Digital Health Advisory Team for North America.
READ MORE >

White House works with health tech companies to address social determinants of health

A number of major health technology companies have partnered with the White House in an effort to standardize the sharing of patient data on social determinants of health.

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

White House works with health tech companies to address social determinants of health

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
A number of major health technology companies have partnered with the White House in an effort to standardize the sharing of patient data on social determinants of health.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Radiology vendor at risk of insolvency | Congress advances rad-backed bill | Uneven AI access drives disparities | CD use common
Best of the Week: AI-generated risk scores help predict breast cancer | $23M verdict after CT misread | Best radiology schools
AI lab invests millions in whole-body imaging venture | Factors influencing AI recalls | AI spots cancer 6 years sooner | More
FDA clears dozens of new radiology AI algorithms | Neuroimaging use on the rise | Tumor segmentation tool nabs clearance
Renal cancer overdiagnoses | Oprah blesses CT scanner | Inappropriate CT use in EDs | Opportunistic AI improves CRC detection
Pigeons help spot abnormalities on CT | AI slashes breast MR imaging times | ACR pushes for physician visa changes
FDA issues warning over 'MRI-safe' claims | Hologic wins patent infringement case | Lower NSA dispute fees enacted | More

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme